{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:26:18Z","timestamp":1791224778078,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"41","license":[{"start":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T00:00:00Z","timestamp":1304294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T00:00:00Z","timestamp":1304294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2011,10,13]]},"DOI":"10.1038\/onc.2011.135","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T10:16:48Z","timestamp":1304331408000},"page":"4261-4274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM\/p53\/p21 pathway is functional"],"prefix":"10.1038","volume":"30","author":[{"given":"G","family":"Lossaint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Besnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Duli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,2]]},"reference":[{"key":"BFonc2011135_CR1","doi-asserted-by":"publisher","first-page":"20480","DOI":"10.1074\/jbc.M213185200","volume":"278","author":"J Ahn","year":"2003","unstructured":"Ahn J, Urist M, Prives C . (2003). Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. J Biol Chem 278: 20480\u201320489.","journal-title":"J Biol Chem"},{"key":"BFonc2011135_CR2","first-page":"7660","volume":"61","author":"PR Andreassen","year":"2001","unstructured":"Andreassen PR, Lacroix FB, Lohez OD, Margolis RL . (2001). Neither p21(WAF1) Nor 14-3-3sigma prevents G(2) progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21(WAF1) induces stable G(1) arrest in resulting tetraploid cells. Cancer Res 61: 7660\u20137668.","journal-title":"Cancer Res"},{"key":"BFonc2011135_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/0008-5472.CAN-07-0675","volume":"68","author":"SJ Arlander","year":"2008","unstructured":"Arlander SJ, Greene BT, Innes CL, Paules RS . (2008). DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells. Cancer Res 68: 89\u201397.","journal-title":"Cancer Res"},{"key":"BFonc2011135_CR4","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1038\/sj.onc.1210881","volume":"26","author":"J Bartek","year":"2007","unstructured":"Bartek J, Bartkova J, Lukas J . (2007). DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26: 7773\u20137779.","journal-title":"Oncogene"},{"key":"BFonc2011135_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","volume":"3","author":"J Bartek","year":"2003","unstructured":"Bartek J, Lukas J . (2003). Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421\u2013429.","journal-title":"Cancer Cell"},{"key":"BFonc2011135_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864\u2013870.","journal-title":"Nature"},{"key":"BFonc2011135_CR7","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1093\/emboj\/cdg387","volume":"22","author":"F Baus","year":"2003","unstructured":"Baus F, Gire V, Fisher D, Piette J, Duli\u0107 V . (2003). Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J 22: 3992\u20134002.","journal-title":"EMBO J"},{"key":"BFonc2011135_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/ncb1599","volume":"9","author":"E Berkovich","year":"2007","unstructured":"Berkovich E, Monnat Jr RJ, Kastan MB . (2007). Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. Nat Cell Biol 9: 683\u2013690.","journal-title":"Nat Cell Biol"},{"key":"BFonc2011135_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccr.2006.10.012","volume":"10","author":"T Bruno","year":"2006","unstructured":"Bruno T, De Nicola F, Iezzi S, Lecis D, D'Angelo C, Di Padova M et al. (2006). Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. Cancer Cell 10: 473\u2013486.","journal-title":"Cancer Cell"},{"key":"BFonc2011135_CR10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","volume":"282","author":"F Bunz","year":"1998","unstructured":"Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497\u20131501.","journal-title":"Science"},{"key":"BFonc2011135_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/44188","volume":"401","author":"TA Chan","year":"1999","unstructured":"Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B . (1999). 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401: 616\u2013620.","journal-title":"Nature"},{"key":"BFonc2011135_CR12","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1101\/gad.14.13.1584","volume":"14","author":"TA Chan","year":"2000","unstructured":"Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B . (2000). Cooperative effects of genes controlling the G(2)\/M checkpoint. Genes Dev 14: 1584\u20131588.","journal-title":"Genes Dev"},{"key":"BFonc2011135_CR13","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1091\/mbc.e03-12-0871","volume":"15","author":"FB Charrier-Savournin","year":"2004","unstructured":"Charrier-Savournin FB, Chateau MT, Gire V, Sedivy J, Piette J, Duli\u0107 V . (2004). p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol Biol Cell 15: 3965\u20133976.","journal-title":"Mol Biol Cell"},{"key":"BFonc2011135_CR14","first-page":"5016","volume":"13","author":"Y Chen","year":"2008","unstructured":"Chen Y, Poon RY . (2008). The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability. Front Biosci 13: 5016\u20135029.","journal-title":"Front Biosci"},{"key":"BFonc2011135_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1158\/1078-0432.CCR-09-1029","volume":"16","author":"Y Dai","year":"2010","unstructured":"Dai Y, Grant S . (2010). New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res 16: 376\u2013383.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011135_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cell.2010.01.031","volume":"141","author":"T Davoli","year":"2010","unstructured":"Davoli T, Denchi EL, de Lange T . (2010). Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141: 81\u201393.","journal-title":"Cell"},{"key":"BFonc2011135_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1083\/jcb.200612047","volume":"176","author":"D Deckbar","year":"2007","unstructured":"Deckbar D, Birraux J, Krempler A, Tchouandong L, Beucher A, Walker S et al. (2007). Chromosome breakage after G2 checkpoint release. J Cell Biol 176: 749\u2013755.","journal-title":"J Cell Biol"},{"key":"BFonc2011135_CR18","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363\u20139367.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011135_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/372467a0","volume":"372","author":"CS Downes","year":"1994","unstructured":"Downes CS, Clarke DJ, Mullinger AM, Gimenez-Abian JF, Creighton AM, Johnson RT . (1994). A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372: 467\u2013470.","journal-title":"Nature"},{"key":"BFonc2011135_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/MCB.18.1.546","volume":"18","author":"V Duli\u0107","year":"1998","unstructured":"Duli\u0107 V, Stein GH, Far DF, Reed SI . (1998). Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2\/M-phase transition. Mol Cell Biol 18: 546\u2013557.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011135_CR21","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1128\/MCB.20.12.4210-4223.2000","volume":"20","author":"PM Flatt","year":"2000","unstructured":"Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA . (2000). p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol Cell Biol 20: 4210\u20134223.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011135_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ccr.2005.10.021","volume":"8","author":"F Foijer","year":"2005","unstructured":"Foijer F, Wolthuis RM, Doodeman V, Medema RH, te Riele H . (2005). Mitogen requirement for cell cycle progression in the absence of pocket protein activity. Cancer Cell 8: 455\u2013466.","journal-title":"Cancer Cell"},{"key":"BFonc2011135_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.200909144","volume":"189","author":"O Gavet","year":"2010","unstructured":"Gavet O, Pines J . (2010). Activation of cyclin B1-Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis. J Cell Biol 189: 247\u2013259.","journal-title":"J Cell Biol"},{"key":"BFonc2011135_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4161\/cc.8.2.7550","volume":"8","author":"LD Gillis","year":"2009","unstructured":"Gillis LD, Leidal AM, Hill R, Lee PW . (2009). p21Cip1\/WAF1 mediates cyclin B1 degradation in response to DNA damage. Cell Cycle 8: 253\u2013256.","journal-title":"Cell Cycle"},{"key":"BFonc2011135_CR25","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1038\/sj.emboj.7600259","volume":"23","author":"V Gire","year":"2004","unstructured":"Gire V, Roux P, Wynford-Thomas D, Brondello JM, Duli\u0107 V . (2004). DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J 23: 2554\u20132563.","journal-title":"EMBO J"},{"key":"BFonc2011135_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nature03485","volume":"434","author":"VG Gorgoulis","year":"2005","unstructured":"Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907\u2013913.","journal-title":"Nature"},{"key":"BFonc2011135_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1128\/MCB.21.4.1066-1076.2001","volume":"21","author":"V Gottifredi","year":"2001","unstructured":"Gottifredi V, Karni-Schmidt O, Shieh SS, Prives C . (2001). p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol Cell Biol 21: 1066\u20131076.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011135_CR28","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1074\/jbc.275.8.5600","volume":"275","author":"PR Graves","year":"2000","unstructured":"Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM et al. (2000). The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 275: 5600\u20135605.","journal-title":"J Biol Chem"},{"key":"BFonc2011135_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","volume":"28","author":"JW Harper","year":"2007","unstructured":"Harper JW, Elledge SJ . (2007). The DNA damage response: ten years after. Mol Cell 28: 739\u2013745.","journal-title":"Mol Cell"},{"key":"BFonc2011135_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","volume":"1","author":"H Hermeking","year":"1997","unstructured":"Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S et al. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2\/M progression. Mol Cell 1: 3\u201311.","journal-title":"Mol Cell"},{"key":"BFonc2011135_CR31","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","volume":"64","author":"I Hickson","year":"2004","unstructured":"Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI et al. (2004). Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64: 9152\u20139159.","journal-title":"Cancer Res"},{"key":"BFonc2011135_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/35077232","volume":"411","author":"JH Hoeijmakers","year":"2001","unstructured":"Hoeijmakers JH . (2001). Genome maintenance mechanisms for preventing cancer. Nature 411: 366\u2013374.","journal-title":"Nature"},{"key":"BFonc2011135_CR33","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1073\/pnas.96.5.2147","volume":"96","author":"SA Innocente","year":"1999","unstructured":"Innocente SA, Abrahamson JL, Cogswell JP, Lee JM . (1999). p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 96: 2147\u20132152.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011135_CR34","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/sj.emboj.7601652","volume":"26","author":"Y Inoue","year":"2007","unstructured":"Inoue Y, Kitagawa M, Taya Y . (2007). Phosphorylation of pRB at Ser612 by Chk1\/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J 26: 2083\u20132093.","journal-title":"EMBO J"},{"key":"BFonc2011135_CR35","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1242\/jcs.02307","volume":"118","author":"MW Jackson","year":"2005","unstructured":"Jackson MW, Agarwal MK, Yang J, Bruss P, Uchiumi T, Agarwal ML et al. (2005). p130\/p107\/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. J Cell Sci 118: 1821\u20131832.","journal-title":"J Cell Sci"},{"key":"BFonc2011135_CR36","doi-asserted-by":"publisher","first-page":"20475","DOI":"10.1074\/jbc.M213159200","volume":"278","author":"PV Jallepalli","year":"2003","unstructured":"Jallepalli PV, Lengauer C, Vogelstein B, Bunz F . (2003). The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J Biol Chem 278: 20475\u201320479.","journal-title":"J Biol Chem"},{"key":"BFonc2011135_CR37","doi-asserted-by":"publisher","first-page":"19322","DOI":"10.1074\/jbc.M802474200","volume":"283","author":"J Jin","year":"2008","unstructured":"Jin J, Ang XL, Ye X, Livingstone M, Harper JW . (2008). Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase. J Biol Chem 283: 19322\u201319328.","journal-title":"J Biol Chem"},{"key":"BFonc2011135_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jmb.2007.06.077","volume":"372","author":"J Jurvansuu","year":"2007","unstructured":"Jurvansuu J, Fragkos M, Ingemarsdotter C, Beard P . (2007). Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling. J Mol Biol 372: 397\u2013406.","journal-title":"J Mol Biol"},{"key":"BFonc2011135_CR39","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrc1714","volume":"5","author":"GJ Kops","year":"2005","unstructured":"Kops GJ, Weaver BA, Cleveland DW . (2005). On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5: 773\u2013785.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011135_CR40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrm2514","volume":"9","author":"MF Lavin","year":"2008","unstructured":"Lavin MF . (2008). Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9: 759\u2013769.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2011135_CR41","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1091\/mbc.e08-08-0818","volume":"20","author":"J Lee","year":"2009","unstructured":"Lee J, Kim JA, Barbier V, Fotedar A, Fotedar R . (2009). DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest. Mol Biol Cell 20: 1891\u20131902.","journal-title":"Mol Biol Cell"},{"key":"BFonc2011135_CR42","first-page":"2500","volume":"55","author":"EN Levedakou","year":"1995","unstructured":"Levedakou EN, Kaufmann WK, Alcorta DA, Galloway DA, Paules RS . (1995). p21CIP1 is not required for the early G2 checkpoint response to ionizing radiation. Cancer Res 55: 2500\u20132502.","journal-title":"Cancer Res"},{"key":"BFonc2011135_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1083\/jcb.200503066","volume":"171","author":"A Lindqvist","year":"2005","unstructured":"Lindqvist A, Kallstrom H, Lundgren A, Barsoum E, Rosenthal CK . (2005). Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J Cell Biol 171: 35\u201345.","journal-title":"J Cell Biol"},{"key":"BFonc2011135_CR44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrc2248","volume":"7","author":"M Lobrich","year":"2007","unstructured":"Lobrich M, Jeggo PA . (2007). The impact of a negligent G2\/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 7: 861\u2013869.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011135_CR45","doi-asserted-by":"publisher","first-page":"a000950","DOI":"10.1101\/cshperspect.a000950","volume":"1","author":"DW Meek","year":"2009","unstructured":"Meek DW, Anderson CW . (2009). Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol 1: a000950.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"BFonc2011135_CR46","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.4161\/cc.8.14.8998","volume":"8","author":"S Meng","year":"2009","unstructured":"Meng S, Arbit T, Veeriah S, Mellinghoff IK, Fang F, Vivanco I et al. (2009). 14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition. Cell Cycle 8: 2238\u20132246.","journal-title":"Cell Cycle"},{"key":"BFonc2011135_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4161\/cc.9.2.10445","volume":"9","author":"C Merry","year":"2010","unstructured":"Merry C, Fu K, Wang J, Yeh IJ, Zhang Y . (2010). Targeting the checkpoint kinase Chk1 in cancer therapy. Cell Cycle 9: 279\u2013283.","journal-title":"Cell Cycle"},{"key":"BFonc2011135_CR48","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0092-8674(03)00401-X","volume":"113","author":"M Narita","year":"2003","unstructured":"Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703\u2013716.","journal-title":"Cell"},{"key":"BFonc2011135_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/CCO.0b013e328333bf00","volume":"22","author":"EI Palmero","year":"2010","unstructured":"Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P . (2010). Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Curr Opin Oncol 22: 64\u201369.","journal-title":"Curr Opin Oncol"},{"key":"BFonc2011135_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccr.2006.11.024","volume":"11","author":"HC Reinhardt","year":"2007","unstructured":"Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB . (2007). p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK\/MK2 pathway for survival after DNA damage. Cancer Cell 11: 175\u2013189.","journal-title":"Cancer Cell"},{"key":"BFonc2011135_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ceb.2009.01.018","volume":"21","author":"HC Reinhardt","year":"2009","unstructured":"Reinhardt HC, Yaffe MB . (2009). Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 21: 245\u2013255.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2011135_CR52","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1128\/MCB.01644-09","volume":"30","author":"A Shibata","year":"2010","unstructured":"Shibata A, Barton O, Noon AT, Dahm K, Deckbar D, Goodarzi AA et al. (2010). Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)\/M checkpoint arrest. Mol Cell Biol 30: 3371\u20133383.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011135_CR53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrc1011","volume":"3","author":"Y Shiloh","year":"2003","unstructured":"Shiloh Y . (2003). ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3: 155\u2013168.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011135_CR54","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2007.12.013","volume":"132","author":"M Shimada","year":"2008","unstructured":"Shimada M, Niida H, Zineldeen DH, Tagami H, Tanaka M, Saito H et al. (2008). Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression. Cell 132: 221\u2013232.","journal-title":"Cell"},{"key":"BFonc2011135_CR55","doi-asserted-by":"publisher","first-page":"30638","DOI":"10.1074\/jbc.M005437200","volume":"275","author":"VA Smits","year":"2000","unstructured":"Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, Medema RH . (2000). p21 inhibits thr161 phosphorylation of cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem 275: 30638\u201330643.","journal-title":"J Biol Chem"},{"key":"BFonc2011135_CR56","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF02618365","volume":"16","author":"M Stampfer","year":"1980","unstructured":"Stampfer M, Hallowes RC, Hackett AJ . (1980). Growth of normal human mammary cells in culture. n vitro 16: 415\u2013425.","journal-title":"n vitro"},{"key":"BFonc2011135_CR57","doi-asserted-by":"publisher","first-page":"10253","DOI":"10.1158\/0008-5472.CAN-06-2144","volume":"66","author":"RG Syljuasen","year":"2006","unstructured":"Syljuasen RG, Jensen S, Bartek J, Lukas J . (2006). Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases. Cancer Res 66: 10253\u201310257.","journal-title":"Cancer Res"},{"key":"BFonc2011135_CR58","doi-asserted-by":"publisher","first-page":"30814","DOI":"10.1074\/jbc.M603747200","volume":"281","author":"H Takemura","year":"2006","unstructured":"Takemura H, Rao VA, Sordet O, Furuta T, Miao ZH, Meng L et al. (2006). Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks. J Biol Chem 281: 30814\u201330823.","journal-title":"J Biol Chem"},{"key":"BFonc2011135_CR59","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","volume":"20","author":"WR Taylor","year":"2001","unstructured":"Taylor WR, Stark GR . (2001). Regulation of the G2\/M transition by p53. Oncogene 20: 1803\u20131815.","journal-title":"Oncogene"},{"key":"BFonc2011135_CR60","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1073\/pnas.0806196106","volume":"106","author":"JE Toettcher","year":"2009","unstructured":"Toettcher JE, Loewer A, Ostheimer GJ, Yaffe MB, Tidor B, Lahav G . (2009). Distinct mechanisms act in concert to mediate cell cycle arrest. Proc Natl Acad Sci USA 106: 785\u2013790.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011135_CR61","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/embor.2009.60","volume":"10","author":"N Tomimatsu","year":"2009","unstructured":"Tomimatsu N, Mukherjee B, Burma S . (2009). Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. EMBO Rep 10: 629\u2013635.","journal-title":"EMBO Rep"},{"key":"BFonc2011135_CR62","doi-asserted-by":"publisher","first-page":"e1000287","DOI":"10.1371\/journal.pbio.1000287","volume":"8","author":"MA van Vugt","year":"2010","unstructured":"van Vugt MA, Gardino AK, Linding R, Ostheimer GJ, Reinhardt HC, Ong SE et al. (2010). A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)\/M DNA damage checkpoint. PLoS Biol 8: e1000287.","journal-title":"PLoS Biol"},{"key":"BFonc2011135_CR63","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.4161\/cc.9.11.11840","volume":"9","author":"MA van Vugt","year":"2010","unstructured":"van Vugt MA, Yaffe MB . (2010). Cell cycle re-entry mechanisms after DNA damage checkpoints: giving it some gas to shut off the breaks!. Cell Cycle 9: 2097\u20132101.","journal-title":"Cell Cycle"},{"key":"BFonc2011135_CR64","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.4161\/cc.7.11.5982","volume":"7","author":"WH Zhang","year":"2008","unstructured":"Zhang WH, Poh A, Fanous AA, Eastman A . (2008). DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G(2) arrest can occur independently of Chk1, Chk2 or MAPKAPK2. Cell Cycle 7: 1668\u20131677.","journal-title":"Cell Cycle"},{"key":"BFonc2011135_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.molcel.2005.07.019","volume":"19","author":"YW Zhang","year":"2005","unstructured":"Zhang YW, Otterness DM, Chiang GG, Xie W, Liu YC, Mercurio F et al. (2005). Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol Cell 19: 607\u2013618.","journal-title":"Mol Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011135","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:26:51Z","timestamp":1647883611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,2]]},"references-count":65,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2011,10,13]]}},"alternative-id":["BFonc2011135"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.135","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,2]]},"assertion":[{"value":"3 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}